Tag Archives: redemption trials

REDEMPTION-1 DAA Trials for Hepatitis C presented at the International Liver Congress 2016

As a part of the effort to solve the unavailability of modern Hepatitis C drugs, REDEMPTION-1 clinical trials were conducted in order to determine the safety and efficacy of generic direct acting antivirals (DAA) to treat Hepatitis C. The trials were lead by Dr. James Freeman of FixHepC Buyers Club who gave a presentation on the outcomes […]

Dr. Freeman’s Presentation at 2016 International Liver Congress – DAA treatment works like a charm!

The International Liver Congress is a 5-day event where scientists and medical experts from all over the globe come up to speed with what is new in the latest liver research. Arguably, it is the biggest event connected with liver diseases in general, and has the biggest impact factor. This year, more than 10,000 scientific […]

Europe plans to eliminate Hepatitis C by 2030

"What would have taken a hundred years for us to achieve, is now at hand!" were the first words of Prof. Angelos Hatzakis who serves at EU Council in Brussels as a co-chair of Hepatitis B and C Public Policy Association. In light of recent discoveries, Europe has presented the so-called Hepatitis C Elimination Manifesto the purpose […]

× Chat